UMR CNRS 5558 Laboratoire de Biométrie et Biologie Évolutive

article :
Goutelle S, Mialou V, Gouraud A, Parant F, Bleyzac N (2011)
Probable Drug Interaction Between Intravenous Ciprofloxacin and Mycophenolate Mofetil in a Bone Marrow Transplant Recipient, Pharmacotherapy, vol. 31(1) pp.36-40

Lecointre R, Bleyzac N (2011)
Infection fongique invasive en oncologie et hématologie pédiatrique : analyse de la littérature et étude médicoéconomique des coûts de prise en charge, Annales Pharmaceutiques Française, vol. PHARMA-186 pp.1-7

Zegbeh H, Bleyzac N, Berhoune C, Bertrand Y (2011)
Vancomycine : quelles doses pour une meilleure efficacité en hémato-oncologie pédiatrique ?, Archives de Pédiatrie, vol. 18 pp.843-934

Berthe A, Duclos A, Ray-Coquard I, Colin C, Bleyzac N (2010)
Evaluation de l`adhésion au référentiel Afssaps sur les antifongiques en hémato-oncologie pédiatrique, Médecine et maladies infectieuses, vol. 3075 pp.1-8

Gérard C, Bleyzac N, Girard A, Freyer G, Bertrand Y, Tod M (2010)
Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model, Pharmaceutical Research, vol. pp.1-12

Gérard C, Bleyzac N, Girard A (2010)
Links Between Cyclosporin Exposure in Tissues and Graft-Versus-Host Disease in Pediatric Bone Marrow Transplantation: Analysis by a PBPK Model, Pharmaceutical Research, vol. pp.1-9

Goutelle S, Larcher R, Padoin C, Mialou V, Bleyzac N (2010)
Oral Voriconazole Dose in children: One size does not fit all, Clinical Infectious Diseases, vol. 51(7) pp.870-870

Bleyzac N (2008)
The use of pharmacokinetic models in paediatric onco-haematology: effects on clinical outcome through the examples of busulfan and cyclosporine, Fundamental & Clinical Pharmacology, vol. 22(6) pp.605-608

Kitio B, Bertholle V, Galambrun C, Mialou V, Bertrand Y, Aulagner G, Bleyzac N (2008)
Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics, Pharmacoepidemiology and Drug Safety, vol. 17(2) pp.135-143

Gellis C, Sautou-Miranda V, Bleyzac N, Jarrige J-F, Minet-Quinard R, Chopineau J (2007)
Continuous infusion of methylprednisolone viapaediatric parenteral nutrition: A pharmacokinetic animal study, Clinical Nutrition, vol. 26 pp.491-497

Brunet AS, Ploton C, Galambrun C, Pondarré C, Pages MP, Bleyzac N, Freydiere A-M, Barbé G, Bertrand Y (2006)
Low Incidence of Sepsis Due to Viridans Streptococci in a Ten-Year Retrospective Study of Pediatric Acute Myeloid Leukemia, Pediatric Blood & Cancer, vol. 47(6) pp.765-772

Duflo F, Sautou-Miranda V, Pouyau A, Taylor P, Combet S, Chotel F, Bleyzac N, Chassard C (2006)
Efficacy and plasma levels of ropivacaine for children: controlled regional analgesia following lower limb surgery, British Journal of Anaesthesia, vol. 97(2) pp.250-254

Duménil-Janoly A, Galambrun C, Basset T, Mialou V, Bertrand Y, Bleyzac N (2006)
Human herpes virus-6 encephalitis in a paediatric bone marrow recipient: successful treatment with pharmacokinetic monitoringand high doses of ganciclovir, Bone Marrow Transplantation, vol. 00 pp.1-2

Levêque N, Galambrun C, Najioullah F, Bleyzac N, Pages MP, Bertrand Y (2006)
Two Cases of Varicella Zoster Virus Meningitis Found in Pediatric Patients After Bone Marrow Transplantation Despite Valaciclovir Prophylaxis and Without Skin Lesions, Journal of Medical Virology, vol. 78(4) pp.514-516

Janoly-Dumenil A, Bleyzac N, Richard I, Bourgeois J, Constant H, Putet G, Maire P, Aulagner G (2003)
Intérêt de l`individualisation des posologies de vancomycine par une méthode bayésienne dans un service de réanimation néonatale, Journal de pharmacie clinique, vol. 22 pp.95-100

Martin P, Bleyzac N, Souillet G, Galambrun C, Bertrand Y , Maire P, Jelliffe RW, Aulagner G (2003)
Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors, Bone Marrow Transplantation, vol. 32 pp.881-887